Food and Drug Regulations
Marginal note:Restriction
G.04.001 (1) Subject to subsections (2) and (3) and to an exemption granted under section 56 of the Act with respect to the administration of the controlled drug specified in the exemption, a practitioner must not administer a controlled drug to any person or animal.
Marginal note:Conditions
(2) A practitioner may administer a controlled drug, other than a designated drug, to a person or to an animal, if
(a) that person or animal is under their professional treatment; and
(b) the controlled drug is required for the condition for which that person or animal is receiving treatment.
Marginal note:Purposes
(3) A practitioner of medicine, dentistry or veterinary medicine or a nurse practitioner may administer a designated drug to a person or animal who is under their professional treatment if the designated drug is for the treatment of any of the following conditions:
(a) in the case of persons,
(i) narcolepsy,
(ii) hyperkinetic disorders in children,
(iii) epilepsy,
(iv) parkinsonism, or
(v) hypotensive states associated with anesthesia; or
(b) in the case of animals, depression of cardiac and respiratory centres.
Marginal note:Definitions
(4) The following definitions apply in this section.
- administer
administer includes to prescribe, sell or provide a drug. (administrer)
- designated drug
designated drug means any of the following controlled drugs:
(a) amphetamine and its salts;
(b) benzphetamine and its salts;
(c) methamphetamine and its salts;
(d) phenmetrazine and its salts; or
(e) phendimetrazine and its salts. (drogue désignée)
- SOR/99-125, s. 4
- SOR/2004-238, s. 23
- SOR/2012-230, s. 12
- SOR/2019-171, s. 13
- Date modified: